BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2016
View Archived Issues
Abeona signs exclusive license for UNC's gene therapy portfolio
Read More
Entasis Therapeutics reports data from phase II study of EXT-0914
Read More
Cidara Therapeutics selects candidate from immunotherapy discovery platform
Read More
The Medicines Company enters strategic partnership with BARDA to develop new antibiotics
Read More
NIH grant supports Feinstein Institute's research into autism spectrum disorders
Read More
SAR-342434 is as efficacious as insulin lispro in T1DM patients
Read More
Bronchiolitis obliterans model created to test reparative effect of stem cell transplantation
Read More
PharmaMar submits MAA to EMA for Aplidin
Read More
Tocagen enrolls first patient in phase Ib for vocimagene amiretrorepvec
Read More
Phase IIb results for the GMZ-2 malaria vaccine in African children
Read More
Teva Pharmaceutical Industries reports positive results in phase III trial of SD-809
Read More
Curemark initiates enrollment for phase III trial evaluating CM-AT in autism
Read More
H. Lundbeck's phase III trial of idalopirdine does not meet primary endpoint
Read More
Selexis expands collaboration with IAVI
Read More
Phase I results encourage further exploration of ABT-555 in multiple sclerosis
Read More
Safety review committee supports continuation of Betalutin trial at higher dose
Read More
EMA premature in notification of SomaKit TOC opinion
Read More
New zebrafish model displays features of 21-hydroxylase deficiency
Read More
FDA grants fast track designation to PfSPZ vaccine
Read More
Promising phase III data on Zykadia in untreated patients with ALK-positive NSCLC
Read More
Phase IIa osteoarthritis study of MIV-711 recommended to continue
Read More
Daiichi Sankyo seeks Japanese approval for Pralia in rheumatoid arthritis
Read More
Genfit validates RORgammat inverse agonist drug candidates for pre-IND studies
Read More
Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia
Read More
Pharmakea describes LOXL2 inhibitors
Read More
Alpharmagen patents nicotinic acetylcholine alpha7 receptor positive allosteric modulators
Read More
Dana-Farber Cancer Institute reports MELK inhibitors
Read More
GlaxoSmithKline prepares and tests bromodomain-containing protein inhibitors
Read More